1. Home
  2. GNSS vs BNTC Comparison

GNSS vs BNTC Comparison

Compare GNSS & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genasys Inc.

GNSS

Genasys Inc.

HOLD

Current Price

$2.20

Market Cap

98.4M

ML Signal

HOLD

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$13.87

Market Cap

405.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNSS
BNTC
Founded
1992
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.4M
405.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GNSS
BNTC
Price
$2.20
$13.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$5.25
$27.67
AVG Volume (30 Days)
158.2K
258.6K
Earning Date
02-10-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$40,757,000.00
N/A
Revenue This Year
$83.82
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
69.76
N/A
52 Week Low
$1.46
$9.70
52 Week High
$3.73
$17.15

Technical Indicators

Market Signals
Indicator
GNSS
BNTC
Relative Strength Index (RSI) 44.53 58.54
Support Level $2.15 $10.99
Resistance Level $2.30 $13.36
Average True Range (ATR) 0.12 0.95
MACD -0.00 0.25
Stochastic Oscillator 54.26 92.15

Price Performance

Historical Comparison
GNSS
BNTC

About GNSS Genasys Inc.

Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Share on Social Networks: